Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cue Biopharma, Inc.

0.7851
-0.0715-8.35%
Volume:136.33K
Turnover:110.19K
Market Cap:59.16M
PE:-1.09
High:0.8566
Open:0.8566
Low:0.7790
Close:0.8566
Loading ...

Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

THOMSON REUTERS
·
01 Apr

Cue Biopharma Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
01 Apr

Cue Biopharma Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
25 Mar

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength?

Zacks
·
17 Mar

Cue Energy Resources First Half 2025 Earnings: EPS: AU$0.006 (vs AU$0.013 in 1H 2024)

Simply Wall St.
·
02 Mar

AGCO to Exhibit New Solutions and AE50 Award Winners at World Ag Expo and National Farm Machinery Show

PR Newswire
·
06 Feb

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
30 Nov 2024

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire
·
25 Nov 2024

Analysts Are Bullish on These Healthcare Stocks: Hookipa Pharma (HOOK), Cue Biopharma (CUE)

TIPRANKS
·
18 Nov 2024

Cue Biopharma Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
17 Nov 2024

Cue Biopharma’s Nasdaq Compliance Struggle: Risks and Implications for Future Stability

TIPRANKS
·
16 Nov 2024

Cue Biopharma Inc : Jefferies Cuts Target Price to $4 From $6

THOMSON REUTERS
·
15 Nov 2024

Cue Biopharma Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
15 Nov 2024

Jefferies Cuts Price Target on Cue Biopharma to $4 From $6, Maintains Buy Rating

MT Newswires Live
·
15 Nov 2024

Stifel Nicolaus Remains a Buy on Cue Biopharma (CUE)

TIPRANKS
·
15 Nov 2024

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
15 Nov 2024

Cue Biopharma Q3 2024 GAAP EPS $(0.17) Beats $(0.19) Estimate, Sales $3.336M Beat $1.520M Estimate

Benzinga
·
15 Nov 2024

Cue Biopharma, Inc. Q3 Net Income USD -8.66 Million

THOMSON REUTERS
·
15 Nov 2024

Cue Biopharma, Inc. Q3 Basic EPS USD -0.17

THOMSON REUTERS
·
15 Nov 2024

Cue names Daniel Baker interim CDO, CSO Amish Suri to transition to advisor role

TIPRANKS
·
14 Nov 2024